Plant-based Diet for Kidney Transplant Recipients
Launched by GEORGE WASHINGTON UNIVERSITY · Dec 15, 2023
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a plant-based diet (PBD) can affect the health of people who have received a kidney transplant. Specifically, researchers want to see if switching to a PBD can improve heart health, reduce inflammation, and help with other related health issues in transplant recipients who are more than three months post-surgery. The study will involve participants following a special program to transition to a plant-based diet for at least 16 weeks while providing samples and completing questionnaires about their health and diet.
To participate, you need to be over three months post-kidney transplant, taking immunosuppressive medication to prevent organ rejection, and have no active infections or major health issues like advanced heart failure or cancer. If you qualify, you'll engage in regular check-ins with the research team and share your experiences on the diet. This trial is an opportunity to contribute to important research that could help improve the lives of kidney transplant recipients through dietary changes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \> 3 months post-kidney transplant
- • On style immunosuppressive medication
- • Without evidence of active infection/ inflammatory conditions
- • Estimated glomerular filtration rate \> 45ml/min/1.73 m\^2
- • English speaking
- • Reliable internet access
- Exclusion Criteria:
- • Acute/ chronic allograft rejection
- • History of non-compliance
- • Advance heart failure
- • Liver disease
- • Pregnancy
- • Malignancy
- • Chronic Infection
- • Currently following a plant-based diet
About George Washington University
George Washington University (GWU) is a leading academic institution dedicated to advancing medical research and education. As a clinical trial sponsor, GWU leverages its extensive resources and expertise to facilitate innovative studies that aim to improve healthcare outcomes. The university's commitment to ethical research practices, collaboration with multidisciplinary teams, and engagement with diverse populations underscores its role in addressing critical health challenges. By fostering a rigorous scientific environment, GWU strives to translate research findings into effective clinical applications, ultimately enhancing patient care and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Washington, District Of Columbia, United States
Patients applied
Trial Officials
Muralidharan Jagadeesan, MD
Principal Investigator
George Washington University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported